Patients with pleural mesothelioma may extend their survival by an estimated 30% when the latest anti-cancer enzyme is added to standard chemotherapy, according…
In early 2023, the world-class Hospital of the University of Pennsylvania will open a groundbreaking clinical trial for mesothelioma patients utilizing a next-generation…
Johnson & Johnson’s controversial bankruptcy filing, designed to limit its soaring talc liabilities, was challenged Sept. 26 before the United States Court of Appeals…
Highly specialized asbestos exposure health screenings in Libby, Montana, have gone mobile. In an effort to identify lung abnormalities at their earliest stage,…
Medical specialists, environmental experts and mesothelioma cancer survivors will be among those gathering for the 17th annual International Asbestos Awareness and Prevention Conference,…
Patients diagnosed with pleural mesothelioma are better managed and survive longer when treated at an integrated specialty center, according to a study by…
Twenty years after being placed on the U.S. Environmental Protection Agency’s National Priorities List, the Libby, Montana, asbestos Superfund site continues its slow…
Your web browser is no longer supported by Microsoft. Update your browser for more security, speed and compatibility.
If you are looking for mesothelioma support, please contact our Patient Advocates at (855) 404-4592
Who Am I Calling?
Calling this number connects you with a Patient Advocate at The Mesothelioma Center, the nation's most trusted mesothelioma resource.
Our Patient Advocates can help guide you or your loved one through the steps to take after a mesothelioma diagnosis. Our team has a combined experience of more than 30 years in assisting cancer patients, and includes a medical doctor, an oncology registered nurse and a U.S. Navy veteran.
